Senate investigations panel to probe Mylan's EpiPen pricing

Reuters News
|
Posted: Sep 07, 2016 3:05 PM

WASHINGTON (Reuters) - The U.S. Senate's permanent subcommittee on investigations has decided to look into Mylan Pharmaceuticals' pricing of the EpiPen, according to a press release issued on Wednesday.

The release described the probe as a "preliminary inquiry."

(Reporting by Diane Bartz; Editing by Chris Reese)